Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Rocket Pharmaceuticals Inc. (RCKT)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 3,567,372 | 0.15 | Add 41.95% | 0.04 | $3.58 | $12,771,192 | SEC |
| 2025 Q4 | 2,513,110 | 0.09 | Reduce 70.32% | 0.26 | $3.51 | $8,821,016 | SEC |
| 2025 Q3 | 8,468,344 | 0.37 | Add 1.25% | <0.01 | $3.26 | $27,606,801 | SEC |
| 2025 Q2 | 8,363,813 | 0.31 | Add 60.87% | 0.12 | $2.45 | $20,491,342 | SEC |
| 2025 Q1 | 5,199,218 | 0.62 | Add 0.01% | $6.67 | $34,678,784 | SEC | |
| 2024 Q4 | 5,198,900 | 1.18 | Add 26.23% | 0.25 | $12.57 | $65,350,173 | SEC |
| 2024 Q3 | 4,118,672 | 1.48 | Add 4.85% | 0.07 | $18.47 | $76,071,872 | SEC |
| 2024 Q2 | 3,928,312 | 1.60 | Add 1.03% | 0.02 | $21.53 | $84,576,557 | SEC |
| 2024 Q1 | 3,888,312 | 1.95 | Reduce 3.61% | 0.09 | $26.94 | $104,751,125 | SEC |
| 2023 Q4 | 4,034,068 | 2.41 | Reduce 28.35% | 0.73 | $29.97 | $120,901,018 | SEC |
| 2023 Q3 | 5,629,970 | 2.59 | Add 28.54% | 0.58 | $20.49 | $115,358,085 | SEC |
| 2023 Q2 | 4,379,970 | 1.86 | Reduce 0.63% | 0.01 | $19.87 | $87,030,004 | SEC |
| 2023 Q1 | 4,407,623 | 1.91 | Add 29.80% | 0.44 | $17.13 | $75,502,582 | SEC |
| 2022 Q4 | 3,395,818 | 1.56 | Add 34.10% | 0.40 | $19.57 | $66,456,158 | SEC |
| 2022 Q3 | 2,532,366 | 0.92 | $15.96 | $40,417,000 | SEC | ||
| 2022 Q2 | 2,532,366 | 0.86 | Add 18.71% | 0.14 | $13.76 | $34,845,000 | SEC |
| 2022 Q1 | 2,133,166 | 0.62 | Add 12.57% | 0.07 | $15.86 | $33,832,000 | SEC |
| 2021 Q4 | 1,894,966 | 0.47 | Add 14.15% | 0.06 | $21.83 | $41,367,000 | SEC |
| 2021 Q3 | 1,660,116 | 0.50 | Add 854.71% | 0.45 | $29.89 | $49,621,000 | SEC |
| 2021 Q2 | 173,887 | 0.07 | Buy | 0.07 | $44.29 | $7,701,000 | SEC |